Ziritaxestat Uses, Dosage, Side Effects and more
Ziritaxestat is under investigation in clinical trial NCT03798366 (A Clinical Study to Test How Effective and Safe GLPG1690 is for Patients With Systemic Sclerosis).
| Trade Name | Ziritaxestat |
| Generic | Ziritaxestat |
| Ziritaxestat Other Names | Ziritaxestat |
| Type | |
| Formula | C30H33FN8O2S |
| Weight | Average: 588.71 Monoisotopic: 588.243121672 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
